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Association between serum vitamin D,  
hs-CRP, and prooxidant-antioxidant balance 
with anthropometric and biochemical  
parameters in patients with diabetic  
foot ulcers
ABSTRACT 
Background. Oxidative balance and inflammatory 
processes affect wound healing phases, and their dis-
ruption is connected with delayed wound healing. The 
present study aimed to assess the association between 
serum hs-CRP, prooxidant-antioxidant Balance (PAB), 
and vitamin D with anthropometric and biochemical 
parameters in patients with diabetic foot ulcers (DFU). 
Methods. Thirty-two patients with DFU were included 
in this study. The Spearman correlation coefficient was 
used to evaluate the bivariate relationship between 
serum hs-CRP, PAB, and vitamin D with anthropometric 
characteristics, glycemic status, lipid profiles, homo-
cysteine level, liver, and kidney function tests.
Results. Our data showed a significant positive asso-
ciation between serum hs-CRP and insulin (r = 0.417, 
P = 0.027), uric acid (r = 0.629, P = 0.001), creatinine 
(r = 0.431, P = 0.022), erythema (r = 0.36, P = 0.049), 
and ESR (r = 0.560, P = 0.002). Moreover, hs-CRP 
negatively correlated with FBS (r = –0.427, P = 0.023), 
total bilirubin (r = –0.639, P = 0.001), direct bilirubin 
(r = –0.445, P = 0.033), lDl-cholesterol (r = –0.405, 
P = –0.032), BMI (r = –0.398, P = 0.033) and HTN 
(r = –0.450, P = 0.014). Serum PAB value negatively 
correlated with patients age (r = –0.460, P = 0.027), 
and BMI (r = –0.442, P = 0.035), and positively as-
sociated with insulin level (r = 0.431, P = 0.040). 
A significant positive association between serum vitamin 
D with patient sex (r = 0.379, P = 0.047), and QUICKI 
(r = 0.456, P = 0.029), and negative correlation with 
HbA1c (r = –0.381, P = 0.045) were also determined.
Conclusions. This study demonstrated that serum hs-
CRP, PAB, and vitamin D are significantly associated 
with some anthropometric and biochemical param-
eters with important clinical value in patients with DFU. 
low levels of vitamin D and high levels of hs-CRP and 
PAB may have an important role in the pathogenesis 
of DFU. (Clin Diabetol 2020; 10, 1: 138–143)
Key words: association, vitamin D, hs-CRP,  
oxidant-antioxidant balance, diabetic foot ulcers
Introduction
Diabetes is a multifactorial disease with a global 
epidemic underway [1]. It has been estimated that the 
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number of patients with diabetes will increase to more 
than 380 million by the year 2025 [2]. The development 
of diabetes is associated with a wide range of complica-
tions, such as micro and macrovascular damages, which 
lead to diabetic foot ulcers (DFU) [3]. DFU is one of the 
most catastrophic diabetes complications associated 
with a high rate of lower extremity amputation among 
diabetic patients [4]. The exact mechanism by which 
diabetes causes these complications is very complex 
and has not been fully understood until date. This 
complication is connected to the direct effect of high 
blood glucose in diabetes. However, the indirect effect 
of oxidative stress, abnormal lipid profiles, chronic in-
flammatory condition, and low level of vitamin D may 
be involved in the progression of DFU [5–7]. 
Oxidative stress results from an imbalance be-
tween oxidant and antioxidant mechanisms within 
the body. Oxidative stress, through the generation 
of reactive oxygen/nitrogen radicals, attacks different 
components of cells such as proteins, carbohydrates, 
nucleic acids, and lipid membranes [8, 9]. Assessment 
of prooxidant-antioxidant balance could be a helpful 
marker of oxidative status to make the right decision 
for proper medical treatment of diabetes. 
Furthermore, it has been proved that high glucose 
in diabetes through the formation of advanced glyca-
tion end-products (AGEs) increases inflammation, 
resulting in worsening disease condition and its com-
plications [10]. Among different inflammation mark-
ers, C-reactive protein (CRP), an acute-phase reactant 
protein, has been regarded as a sensitive marker of 
systemic inflammation [11]. Interleukin-1 (IL-1), IL-6, 
and tumor necrosis factor-alpha (TNF-a) regulate CRP 
production within the liver [12]. Lately, more sensitive 
immunoassays for CRP measurement (high sensitivity 
CRP, hs-CRP) have become available and made this pos-
sible to measure the low quantity of CRP and compare 
it with other inflammatory parameters in the blood 
[13]. Previous studies revealed a relationship between 
hs-CRP levels and the development and progression 
of coronary heart disease (CHD) and osteoarthritis 
[14, 15]. PAB is a simple assay, which measures total 
prooxidants and antioxidants within one assay. It makes 
it possible to understand the role of oxidative stress in 
the pathophysiology of many diseases such as diabetes 
and its complications such as DFU [16]. 
Moreover, previous studies found that a low level 
of vitamin D is a possible risk factor for type 2 diabetes. 
Interestingly, they have shown an inverse relationship 
between serum vitamin D and the incidence of DFU 
[17]. Therefore, in the present study, we aimed to evalu-
ate the association of serum vitamin D, hs-CRP, and 
oxidative balance with anthropometric characteristics, 
glycemic status, lipid profiles, homocysteine level, liver, 
and kidney function tests in patients with DFU.
Methods
Patients 
This study was performed among thirty-two pa-
tients with DFU referred to the Alavi Vascular Surgery 
Hospital in Mashhad, Iran. The ethics committee of 
the Mashhad University of Medical Sciences approved 
the study protocol (registration number: IR.MUMS.
REC.1398.251). Written informed consent was obtained 
from each participant.
Clinical measurements 
After an initial assessment of disease conditions, 
anthropometric measurements were obtained. Follow-
ing overnight fasting, patients’ weight was determined 
by a standard scale (EmsiG, Hamburg, Germany). 
The participants’ height was measured using a non-
stretched tape measure (EmsiG, Hamburg, Germany) 
to the nearest 0.1 cm. Then, BMI was calculated as 
body weight in kilograms divided by height in meters 
squared. All patients answered the required clinical and 
epidemiological assessment evaluating the treatment 
with insulin, metformin, and other oral hypoglycemic 
drugs, hypertension, time of diabetes diagnosis, and 
the development of any chronic complications related 
to diseases. All data were confirmed by a review of the 
patient’s medical records. 
laboratory analysis 
Venous blood samples (10 mL) were taken from 
all patients following overnight fasting. Then, blood 
was centrifuged at 2500 X g for 15 min at 4 °C to 
separate serum. Serum vitamin D was determined using 
a commercial ELISA kit (ZellBio, Veltlinerweg, Germany). 
Serum hs-CRP was measured using a commercial ELISA 
kit (ZellBio, Veltlinerweg, Germany) with a microplate 
reader (Rosys Anthos 2010, Wals, Austria). Serum 
prooxidant-antioxidant balance (PAB) was measured 
based on a previous method developed by Hamidi 
Alamdari [18]. Serum ESR was obtained by the West-
ergren methods [19]. Homocysteine was measured by 
a commercial ELISA kit (Aviva, California, USA). HbA1c 
levels were evaluated by the Glycomat kit (BiocodeHy-
cel, Massy, France). Serum insulin concentrations were 
obtained by a commercial ELISA kit (Mercodia, Uppsala, 
Sweden). All the inter- and intra-assay CVs for serum 
vitamin D, hs-CRP, homocysteine, HbA1c, and insulin 
concentrations were less than 5%. The homeostasis 
model of assessment-insulin resistance (HOMA-IR) and 
the quantitative insulin sensitivity check index (QUICKI) 
were calculated based on the suggested formulas [20]. 
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We have used Enzymatic kits to evaluate serum fasting 
blood sugar (FBS), triglycerides (TG), urea, creatinine, 
uric acid, cholesterol (Chol), VLDL-Chol, LDL-Chol, HDL- 
-Chol, total bilirubin, alkaline phosphatase (ALP), ala-
nine aminotransferase (ALT), and aspartate aminotrans-
ferase (AST) according to the manufacturer protocols 
(Pars Azmun, Tehran, Iran). All the inter- and intra-assay 
CVs for serum FBS, urea, creatinine, uric acid, bilirubin, 
ALP, ALT, AST, and lipid profiles were less than 5%. Al-
bumin concentrations were obtained by a commercial 
ELISA kit (Pars Azmun, Tehran, Iran).
Statistical analysis
Data are presented as the mean ± standard devia-
tion (SD). The Spearman correlation coefficient was 
used to evaluate the bivariate relationship between 
serum levels of vitamin D, hs-CRP, and PAB with anthro-
pometric characteristics, glycemic status, lipid profiles, 
homocysteine level, liver, and kidney function tests. 
P < 0.05 was considered as the level of significance. All 
statistical analyses were performed using the SPSS 22 
statistical package (SPSS22, Chicago, IL, USA).
Results
The baseline anthropometric and clinical charac-
teristics of study subjects are presented in Table 1. This 
study was performed among thirty-two patients with 
DFU, in which 21 patients (65.6%) had at least one 
insulin daily injection, and 18 patients (56.2%) used 
oral metformin. 17 patients (53.1%) had a history of 
hypertension (HTN) and consumed oral antihyperten-
sive drugs. The mean BMI of the study participants 
was 25.1 ± 3.8.
Biochemical parameters of study subjects are 
listed in Table 2. As shown in Table 3, the correlation 
coefficient revealed that the serum levels of hs-CRP 
was positively associated with insulin (r = 0.417, 
P = 0.027), uric acid (r = 0.629, P = 0.001), creatinine 
(r = 0.431, P = 0.022), erythema (r = 0.36, P = 0.049), 
and ESR (r = 0.560, P = 0.002). Also, our results showed 
that hs-CRP levels negatively correlated with BMI 
(r = –0.398, P = 0.033), HTN (r = –0.450, P = 0.014), 
FBS (r = –0.427, P = 0.023), total bilirubin (r = –0.639, 
P = 0.001), direct bilirubin (r = –0.445, P = 0.033) and 
LDL-cholesterol (r = –0.405, P = –0.032). There was no 
Table 1. Anthropometric and clinical characteristics of the 
study participants
Trait value
Age (year) 58.5 ± 9.4
Sex (male/female) 20/12
Diabetes duration (year) 12.4 ± 7.1
Type 2 diabetes (%) 32 (100) 
Insulin injection (%) 21 (65.6)
Metformin therapy (%) 18 (56.2)
Glibenclamide therapy (%) 6 (18.7)
HTN (%) 17 (53.1)
Retinopathy (%) 19 (59.3)
Previous amputation (%) 12 (37.5)
Ulcer symptoms
Erythema (%) 22 (68.7)
Discharge (%) 14 (43.8)
Necrosis (%) 11 (34.3)
Height 175.6 ± 5.5
Weight 77.1 ± 11.6
BMI 25.1 ± 3.8
All values are presented as means ± SDs; BMI — body mass index;  
HTN — hypertension
Table 2. Baseline biochemical parameters of the study 
participants 
Parameter value
FBS [mg/dL] 141.2 ± 39.7
Insulin [µIU/mL] 14.9 ± 12.5
HOMA-IR 5.0 ± 3.9
QUICKI 0.31 ± 0.03
HbA1c (%) 9.8 ± 1.7
Uric acid [mg/dL] 5.3 ± 1.5
Urea [mg/dL] 40.7 ± 22.1
Creatinine [mg/dL] 1.0 ± 0.37
Triglycerides [mg/dL] 120.6 ± 59.0
Total cholesterol [mg/dL] 147.6 ± 35.2
VLDL cholesterol [mg/dL] 24.0 ± 11.7
LDL cholesterol [mg/dL] 74.4 ± 27.9
HDL cholesterol [mg/dL] 2.1 ± 16.7
Total-/HDL-cholesterol ratio 3.8 ± 1.1
Bilirubin total [mg/dL] 0.45 ± 0.37
Bilirubin direct [mg/dL] 0.20 ± 0.09
ALP [IU/L] 189.3 ± 69.4
AST [IU/L] 19.6 ± 4.7
ALT [IU/L] 18.0 ± 7.9
Albumin [g/dL] 4.3 ± 0.41
Homocysteine [µmol/L] 9.9 ± 3.4
Vitamin D3 [ng/mL] 25.3 ± 20.0
ESR [mm/h] 41.4 ± 38.5
hs-CRP [mg/L] 24.7 ± 29.4
PAB (HK unit) 169.5 ± 47.4
All values are presented as means ± SDs; BMI — body mass index; HTN — 
hypertension; FBS — fasting blood sugar; HOMA-IR — homeostasis model 
of assessment-insulin resistance; QUICKI — quantitative insulin sensitivity 
check index; HbA1c — hemoglobin A1c, hs-CRP — high-sensitivity  
C-reactive protein; ESR — erythrocyte sedimentation rate; ALP — alkaline 
phosphatase; AST — aspartate aminotransferase; ALT — alanine  
aminotransferase; PAB — prooxidant-antioxidant balance
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significant correlation between hs-CRP level and age, 
sex, height, weight, other biochemical parameters 
including TG, cholesterol, albumin, vitamin D3, homo-
cysteine, PAB and liver function tests. 
A significant and negative associations were found 
between PAB and patients age (r = –0.460, P = 0.027), 
BMI (r = –0.442, P = 0.035), and a positive correlation 
of PAB with insulin (r = 0.431, P = 0.040) was also ob-
served. Moreover, a positive and marginal association 
between PAB value and HbA1c were seen (r = 0.410, 
P = 0.052) in patients with DFU. Our data showed 
that there was not any significant correlation between 
PAB value and other anthropometric and biochemical 
parameters, as shown in Table 3. 
Vitamin D positively associated with sex (r = 0.379, 
P = 0.047) and QUICKI (r = 0.456, P = 0.029). Fur-
thermore, a negative correlation between serum 
vitamin D and HbA1c (r = –0.381, P = 0.045) were 
also determined (Table 3). There was no significant 
association between serum vitamin D, anthropometric 
Table 3. Correlation between serum hs-CRP, PAB, and vitamin D with anthropometric and biochemical parameters in 
patients with DFU 
 Serum hs-CRP values  Serum PAB values  Serum Vitamin D
 r values P values  r values P values  r values P values
Age  –0.286 0.131 –0.460 0.027 0.284  0.143
Sex  –0.121 0.530 0.299 0.166 0.379 0.047
Diabetes duration (year)  –0.073 0.708 –0.056 0.799 0.112 0.571
Height 0.045 0.816 0.355 0.096 0.281 0.147
Weight –0.344 0.068 –0.293 0.175 0.037 0.851
BMI   –0.398 0.033 –0.442 0.035 –0.036 0.856
HTN   –0.450 0.014 –0.013 0.953 –0.027 0.893
FBS [mg/dL]   –0.427 0.023 –0.230 0.290 –0.230 0.239
Insulin [µIU/mL]  0.417 0.027 0.431 0.040 –0.081 0.682
HOMA-IR 0.196 0.317 0.247 0.257 –0.314 0.104
QUICKI –0.205 0.296 –0.245 0.260 0.456 0.029
HbA1c (%)  0.001 0.998 0.410 0.052 –0.381 0.045
Uric Acid [mg/dL]  0.629 0.001 0.224 0.304 –0.018 0.929
Urea [mg/dL]   0.147 0.456 –0.171 0.435 –0.221 0.259
Creatinine [mg/dL] 0.431 0.022 –0.070 0.750 –0.029 0.882
Triglycerides [mg/dL]  0.001 0.999 –0.055 0.802 –0.149 0.449
Total cholesterol [mg/dL] 0.344 0.073 0.113 0.607 –0.044 0.825
VLDL cholesterol [mg/dL]   –0.001 0.997 –0.051 0.817 –0.166 0.399
LDL cholesterol [mg/dL]  –0.405 0.032 0.037 0.867 –0.014 0.945
HDL cholesterol [mg/dL] 0.265  0.173 –0.039 0.861 –0.038 0.848
Total-/HDL-cholesterol ratio 0.060 0.786 0.015 0.946 –0.089 0.687
Bilirubin total [mg/dL] –0.639 0.001 0.081 0.713 0.149 0.448
Bilirubin direct [mg/dL]  –0.445 0.033 –0.354 0.14 0.140 0.523
ALP [IU/L] 0.362 0.058 0.191 0.383 0.001 0.998
AST [IU/L] –0.095 0.629 0.017 0.937 0.037 0.853
ALT [IU/L] –0.259 0.184 0.104 0.636 0.040 0.839
Albumin [g/dL] –0.265 0.174 0.232 0.286 0.143 0.467
Homocysteine [µmol/L] 0.202 0.303 0.267 0.218 0.004 0.983
Vitamin D3 [ng/mL]  –0.010 0.958 0.263 0.226 – –
ESR [mm/h]  0.560 0.002 0.061 0.781 –0.032 0.871
hs-CRP [mg/L] – – 0 .281 0.194 –0.010 0.958
PAB (HK unit) 0.281 0.194 – – 0.263 0.226
r value represent Spearman correlation coefficient; P values represent Spearman correlation test
All values are presented as means ± SDs; BMI — body mass index; HTN — hypertension; FBS — fasting blood sugar; HOMA-IR — homeostasis model of 
assessment-insulin resistance; QUICKI — quantitative insulin sensitivity check index; HbA1c — hemoglobin A1c; hs-CRP — high-sensitivity C-reactive protein; 
ESR — erythrocyte sedimentation rate; ALP — alkaline phosphatase; AST — aspartate aminotransferase; ALT — alanine aminotransferase; PAB — prooxi-
dant-antioxidant balance
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characteristics and other biochemical parameters as 
documented in Table 3. 
Discussion
The present study results showed that the hs-CRP 
level is associated with glycemic (FBS and insulin), oxi-
dative, and inflammatory markers in patients with DFU. 
Similar reports were published by some investigators, 
which showed that hyperglycemia promotes oxidative 
and inflammatory markers in patients with diabetes 
[21]. CRP, a member of acute-phase reactant proteins, 
has been used widely as a marker of cardiovascular 
complications [22]. It has been suggested that CRP 
has direct pro-inflammatory effects, and assessment of 
CRP (as hs-CRP) could be a valid marker for evaluating 
inflammatory problems during diseases [[23. Similar 
to our study, Zubair et al. [24] showed a correlation 
between hs-CRP and BMI, LDL-cholesterol, and ne-
phropathy in patients with DFU. In our study, we saw 
a significant correlation between hs-CRP and creatinine 
level, which is the best marker of diabetic nephropathy. 
Numerous data demonstrated that inflammation plays 
an important role in the pathophysiology of DFU [25]. 
Also, it has been proven that insulin sensitivity or insulin 
resistance is an inflammatory process [26], as shown in 
our study that hs-CRP had a positive correlation with 
insulin and ESR level. Moreover, we found a significant 
and negative correlation between PAB and age (r = 
= –0.460, P = 0.027), and BMI (r = –0.442, P = 0.035); 
however, there was no significant association between 
PAB and other inflammatory and biochemical markers 
in serum of patients with DFU. Besides, we did not find 
any significant correlation between hs-CRP and PAB 
with homocysteine and vitamin D level in DFU patients. 
Consistent with our results, Jung et al. [27] showed 
that serum vitamin D level positively correlated with 
a patient’s sex. Also, our data revealed a significant neg-
ative correlation between serum vitamin D and HbA1c. 
Similar to our study Buhary et al. [28] also found that 
HbA1c was inversely related to serum vitamin D levels 
(r = –0.14, P < 0.001) [28]. A meta-analysis by Lee 
et al. [29] showed that vitamin D supplementation re-
sulted in a modest reduction of HbA1c in type2 diabetic 
patients. In summary, we found a correlation between 
hs-CRP and glycemic, oxidative, and inflammatory 
markers in patients with DFU. Furthermore, there was 
a significant correlation between vitamin D and HBA1c 
level, and there was no correlation between vitamin D 
and other biochemical parameters. A high level of hs-
CRP may predict the progression of diabetes and may 
have an important role in the pathogenesis of diabetes 
complications. We had a few limitations in our study; it 
was a single-center study with relatively small sample 
size. A multicenter study involving a higher number of 
patients is recommended.
Conclusions
In conclusion, the results of this study demonstrate 
that serum hs-CRP, PAB, and vitamin D are significantly 
associated with some anthropometric and biochemical 
parameters with important clinical value in patients 
with DFU. Low levels of vitamin D and high levels of 
hs-CRP and PAB may have an important role in the 
pathogenesis of DFU.
Figure 1. Three patients with DFU; A — a 54 years old woman with DFU for 3 months; B — a 49 years old woman with DFU for 
18 months; C — a 51 years old man with DFU for 12 months
A B C
Amir Yarahmadi et al., Association between vitamin D, hs-CRP, and PAB with biochemical parameters
143
Acknowledgments
This study has been extracted from the PhD thesis 
of Amir Yarahmadi, conducted in Vascular and Endo-
vascular Surgery Research Center of Mashhad University 
of Medical Sciences, Mashhad, Iran. 
Funding
This work was supported by the Research Council 
at Mashhad University of Medical Sciences under Grant 
number 971636.
Conflict of interest
The authors declare that they have no conflict of 
interest related to this manuscript.
REFERENCES
1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of 
the diabetes epidemic. Nature. 2001; 414(6865): 782–787, doi: 
10.1038/414782a, indexed in Pubmed: 11742409.
2. Zimmet P, Alberti KG, Magliano DJ, et al. Diabetes mellitus statis-
tics on prevalence and mortality: facts and fallacies. Nat Rev En-
docrinol. 2016; 12(10): 616–622, doi: 10.1038/nrendo.2016.105, 
indexed in Pubmed: 27388988.
3. Dee T, Sukartini T, Probowati R. Factors associated with foot 
ulcer among diabetic patients. Int J Nurs Sci Health Serv. 2020; 
3(3): 771–776.
4. Martins-Mendes D, Monteiro-Soares M, Boyko EJ, et al. The in-
dependent contribution of diabetic foot ulcer on lower extremity 
amputation and mortality risk. J Diabetes Complications. 2014; 
28(5): 632–638, doi: 10.1016/j.jdiacomp.2014.04.011, indexed 
in Pubmed: 24877985.
5. Singh SK, Sahay RK, Krishna A. Oxidative stress in diabetic 
foot ulcer. Diabetes & Metabolic Syndrome: Clinical Research 
& Reviews. 2008; 2(2): 109–113, doi: 10.1016/j.dsx.2008.02.003.
6. Zubair M, Malik A, Meerza D, et al. 25-Hydroxyvitamin D [25(OH)
D] levels and diabetic foot ulcer: is there any relationship? 
Diabetes Metab Syndr. 2013; 7(3): 148–153, doi: 10.1016/j.
dsx.2013.06.008, indexed in Pubmed: 23953180.
7. Yarahmadi A, Zal F, Bolouki A. Protective effects of quercetin on nic-
otine induced oxidative stress in ‘HepG2 cells’. Toxicol Mech Meth-
ods. 2017; 27(8): 609–614, doi: 10.1080/15376516.2017.1344338, 
indexed in Pubmed: 28627253.
8. Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev 
Biochem. 2017; 86: 715–748, doi: 10.1146/annurev-bio-
chem-061516-045037, indexed in Pubmed: 28441057.
9. Yarahmadi A, Khademi F, Mostafavi-Pour Z, et al. In-vitro analysis 
of glucose and quercetin effects on m-TOR and Nrf-2 expression 
in HepG2 cell line (diabetes and cancer connection). Nutr Cancer. 
2018; 70(5): 770–775, doi: 10.1080/01635581.2018.1470654, 
indexed in Pubmed: 29781726.
10. Khan R, Ooi XY, Parvus M, et al. Advanced glycation end products: 
formation, role in diabetic complications, and potential in clinical 
applications. The Eye and Foot in Diabetes. 2020, doi: 10.5772/
intechopen.89408.
11. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of 
inflammation and infection. Front Immunol. 2018; 9: 754, doi: 
10.3389/fimmu.2018.00754, indexed in Pubmed: 29706967.
12. Ahmad J, Zubair M, Malik A, et al. Cathepsin-D, adiponectin, 
TNF-a, IL-6 and hsCRP plasma levels in subjects with diabetic 
foot and possible correlation with clinical variables: a multicen-
tric study. Foot (Edinb). 2012; 22(3): 194–199, doi: 10.1016/j.
foot.2012.03.015, indexed in Pubmed: 22560191.
13. Windgassen EB, Funtowicz L, Lunsford TN, et al. C-reactive 
protein and high-sensitivity C-reactive protein: an update for 
clinicians. Postgrad Med. 2011; 123(1): 114–119, doi: 10.3810/
pgm.2011.01.2252, indexed in Pubmed: 21293091.
14. Rifai N, Ridker P. High-sensitivity C-reactive protein: a novel and 
promising marker of coronary heart disease. Clinical Chemistry. 
2001; 47(3): 403–411, doi: 10.1093/clinchem/47.3.403.
15. Pearle AD, Scanzello CR, George S, et al. Elevated high-sensitivity 
C-reactive protein levels are associated with local inflammatory 
findings in patients with osteoarthritis. Osteoarthritis Cartilage. 
2007; 15(5): 516–523, doi: 10.1016/j.joca.2006.10.010, indexed 
in Pubmed: 17157039.
16. Hamidi Alamdari D, Bagheri Moghaddam A, Amini S, et al. The 
application of a reduced dye used in orthopedics as a novel treat-
ment against coronavirus (COVID-19): a suggested therapeutic 
protocol. Arch Bone Jt Surg. 2020; 8(Suppl1): 291–294, doi: 
10.22038/abjs.2020.47745.2349, indexed in Pubmed: 32607398.
17. Dai J, Jiang C, Chen H, et al. Vitamin D and diabetic foot ulcer: a 
systematic review and meta-analysis. Nutr Diabetes. 2019; 9(1): 8, 
doi: 10.1038/s41387-019-0078-9, indexed in Pubmed: 30858355.
18. Alamdari DH, Paletas K, Pegiou T, et al. A novel assay for the 
evaluation of the prooxidant-antioxidant balance, before and 
after antioxidant vitamin administration in type II diabetes 
patients. Clin Biochem. 2007; 40(3–4): 248–254, doi: 10.1016/j.
clinbiochem.2006.10.017, indexed in Pubmed: 17196578.
19. Sikka M, Tandon R, Rusia U, et al. Validation of ESR analyzer using 
Westergren ESR method. Indian J Pathol Microbiol. 2007; 50: 634.
20. Borai A, Livingstone C, Kaddam I, et al. Selection of the appropri-
ate method for the assessment of insulin resistance. BMC Med 
Res Methodol. 2011; 11: 158, doi: 10.1186/1471-2288-11-158, 
indexed in Pubmed: 22112229.
21. Aronson D. Hyperglycemia and the pathobiology of diabetic com-
plications. Adv Cardiol. 2008; 45: 1–16, doi: 10.1159/000115118, 
indexed in Pubmed: 18230953.
22. Yeh ET, Anderson HV, Pasceri V, et al. C-reactive protein: link-
ing inflammation to cardiovascular complications. Circulation. 
2001; 104(9): 974–975, doi: 10.1161/01.cir.104.9.974, indexed 
in Pubmed: 11524386.
23. Liang YJ, Liu YC, Chen CY, et al. Comparison of PPARd and PPARg 
in inhibiting the pro-inflammatory effects of C-reactive protein 
in endothelial cells. Int J Cardiol. 2010; 143(3): 361–367, doi: 
10.1016/j.ijcard.2009.03.100, indexed in Pubmed: 19395102.
24. Zubair M, Malik A, Ahmad J. Plasma adiponectin, IL-6, hsCRP, and 
TNF-‎ levels in subject with diabetic foot and their correlation with 
clinical variables in a North Indian tertiary care hospital. Indian 
J Endocrinol Metab. 2012; 16(5): 769–776, doi: 10.4103/2230-
8210.100672, indexed in Pubmed: 23087862.
25. Mi Qi, Rivière B, Clermont G, et al. Agent-based model of inflam-
mation and wound healing: insights into diabetic foot ulcer 
pathology and the role of transforming growth factor-beta1. 
Wound Repair Regen. 2007; 15(5): 671–682, doi: 10.1111/j.1524-
475X.2007.00271.x, indexed in Pubmed: 17971013.
26. Hotamisligil GS. Inflammatory pathways and insulin action. Int 
J Obes Relat Metab Disord. 2003; 27 Suppl 3: S53–S55, doi: 
10.1038/sj.ijo.0802502, indexed in Pubmed: 14704746.
27. Jung CH, Kim KJ, Kim BY, et al. Relationship between vitamin D 
status and vascular complications in patients with type 2 dia-
betes mellitus. Nutr Res. 2016; 36(2): 117–124, doi: 10.1016/j.
nutres.2015.11.008, indexed in Pubmed: 26826427.
28. Buhary BM, Almohareb O, Aljohani N, et al. Association of glyco-
sylated hemoglobin levels with vitamin D status. J Clin Med Res. 
2017; 9(12): 1013–1018, doi: 10.14740/jocmr3227w, indexed in 
Pubmed: 29163736.
29. Lee CJ, Iyer G, Liu Y, et al. The effect of vitamin D supplemen-
tation on glucose metabolism in type 2 diabetes mellitus: 
A systematic review and meta-analysis of intervention studies. 
J Diabetes Complications. 2017; 31(7): 1115–1126, doi: 10.1016/j.
jdiacomp.2017.04.019, indexed in Pubmed: 28483335.
